B+
Bull case
25%
Probability
Target price
$47.03
+4.6% vs current
Analyst consensus targets sit well above the current price, signaling institutional expectation of recovery. Near-term market tone is cautious due to renewal and execution risk, supporting a conservative base case while leaving upside if catalysts materialize.
No evidence quality warning is currently attached to this memo.
Earnings may update subscription net retention and ARR; date unconfirmed—estimated 90 days out. [#SERP-9]
Outcomes at a few large customers could swing near-term revenue visibility; timing unclear, conservative window assumed.
Sustained adoption and cross-sell could re-rate the stock over a 12-month horizon; set as a one-year checkpoint.
No formal recommendation provided.